Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
01/2008
01/09/2008CN100360519C Benzothiepine ileal bile acid transport inhibitors
01/09/2008CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas
01/09/2008CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors
01/09/2008CN100360130C 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
01/08/2008US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
01/08/2008US7317102 Diarylmethyl and related compounds
01/08/2008US7317034 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds
01/08/2008US7317033 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
01/08/2008US7317032 Imidazolyl inhibitors of 15-lipoxygenase
01/08/2008US7317031 3-(SO2-substituted anilino)-5-amino-1-((hetero)aryl-carbonyl- or sulfonyl)-1H-1,2,4-triazoles: 4-[[5-amino-1-[(3-methyl-2-thienyl)carbonyl]-1H-1,2,4-triazol-3-yl]amino]-benzenesulfonamide; for treating melanoma; cervical, ovarian and prostate adenocarcinoma; colon carcinoma and breast cancer
01/08/2008US7317025 Non-peptidic NPY Y2 receptor inhibitors
01/08/2008US7317022 3-isopropyl-2-oxo-2,3-dihydrobenzoimidazole-1-carboxylic acid [(1S,3R,5R)-8-((S)-2-hydroxy-3-methylamino-propyl)-8-azabicyclo[3.2.1]oct-3-yl]-amide; bioavailability upon oral administration; medical conditions mediated by 5-HT4 receptor activity
01/08/2008CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
01/08/2008CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
01/08/2008CA2172513C Aminocyclohexylesters and uses thereof
01/03/2008WO2008002974A1 Pyrrole derivatives and their methods of use
01/03/2008WO2008001931A2 Fused cyclic compounds
01/03/2008WO2008000643A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
01/03/2008WO2008000407A1 Inhibitors of cxcr2
01/03/2008WO2007125331A3 Amino-ethyl-amino-aryl (aeaa) compounds and their use
01/03/2008WO2007120729A3 Pyridyl amide t-type calcium channel antagonists
01/03/2008WO2007113005A3 2-substituted 3-aminosulfonyl-thiophene derivatives as aurora kinase inhibitors
01/03/2008WO2007089626A3 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
01/03/2008WO2005019200A3 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
01/03/2008US20080004415 Non-linear optically active molecules, their synthesis, and use
01/03/2008US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
01/03/2008US20080004288 Indazole Sulphonamide Derivatives
01/03/2008US20080004275 Antiviral 4-Aminocarbonylamino-Substituted Imidazole Compounds
01/03/2008US20080004245 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
01/03/2008US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
01/03/2008CA2658362A1 Metalloprotease inhibitors
01/03/2008CA2656003A1 Fused cyclic compounds
01/03/2008CA2647601A1 Pyrrole derivatives and their methods of use
01/02/2008EP1873144A1 Fused heterocyclic compound
01/02/2008EP1871766A1 Antifungal triazole derivatives
01/02/2008EP1871759A1 Benzodioxane and benzodioxolane derivatives and uses thereof
01/02/2008EP1871746A1 Substituted n-[ypyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators
01/02/2008EP1871374A2 2,3 substituted pyrazine sulfonamides as inhibitors of crth2
01/02/2008EP1474422B1 R-(-)-1-¬2-(7-CHLOROBENZO-¬B -THIOPHEN-3-Yl-METHOXY)-2-(2,4-DICHLOROPHENYL)ETHYL -1H-IMIDAZOLE
01/02/2008EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor
01/02/2008EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
01/02/2008EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
01/02/2008EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
01/02/2008CN101099286A Method and installation means for installing an electrical machine
01/02/2008CN101098858A 吲唑磺酰胺衍生物 Indazole sulfonamide derivative
01/02/2008CN101098857A Nitro indazole derivatives
01/02/2008CN101098855A 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
01/02/2008CN100358891C Pyranones useful as ATM inhibitors
01/02/2008CN100358877C Process for preparation of fungicidal compositions
01/02/2008CN100358870C Aminotetralin derivatives as muscarinic receptor antagonists
01/01/2008USRE39991 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/01/2008US7314938 Immune and/or inflammatory disorders; autoimmune disorders; disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1); antagonize CD11/CD18 receptors associated with leukocytes.
01/01/2008US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
01/01/2008US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile
01/01/2008US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases
01/01/2008US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders
01/01/2008US7314874 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo
01/01/2008US7314870 Compounds, their preparation and use
12/2007
12/27/2007WO2007149512A2 Peptide epoxyketones for pr0teas0me inhibition
12/27/2007WO2007149478A2 Pyrazine derivatives with extended conjugation and uses thereof
12/27/2007WO2007149448A2 Pyrazinones as cellular proliferation inhibitors
12/27/2007WO2007149105A2 Fluorescein based sensors for tracking nitric oxide in live cells
12/27/2007WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
12/27/2007WO2007148774A1 Cyclic amine compound
12/27/2007WO2007148185A2 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
12/27/2007WO2007147841A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
12/27/2007WO2007147778A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
12/27/2007WO2007120284A3 Glucagon receptor antagonists, preparation and therapeutic uses
12/27/2007WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
12/27/2007US20070299264 Method to control insects resistant to common insecticides
12/27/2007US20070299125 Substituted indoles
12/27/2007US20070299109 Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders
12/27/2007US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer
12/27/2007US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299057 Heterocyclic piperidines as modulators of chemokine receptor activity
12/27/2007US20070299056 Benzazepine derivatives for the treatment of neurological disorders
12/27/2007US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
12/27/2007US20070297976 Metal Ion-Labeled Bis-Aminoethanethiol-Targeting Ligand Conjugates, Compositions, and Methods for Tissue-Specific Imaging
12/27/2007US20070295398 Conducting Polymers With Porphyrin Cross-Linkers
12/27/2007CA2657967A1 Cyclopentane derivatives as antiglaucoma agents
12/27/2007CA2657213A1 Peptide epoxyketones for proteasome inhibition
12/27/2007CA2655857A1 Pyrazine derivatives with extended conjugation and uses thereof
12/27/2007CA2654689A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
12/27/2007CA2652859A1 Pyrazinones as cellular proliferation inhibitors
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1869040A1 Dna-pk inhibitors
12/26/2007EP1869026A1 Novel compounds
12/26/2007EP1869025A1 Piperazine-substituted benzothiophenes for treatment of mental disorders
12/26/2007EP1869024A1 New tricyclic angiotensin ii agonists
12/26/2007EP1869023A1 New tricyclic angiotensin ii agonists
12/26/2007EP1869021A1 Dna-pk inhibitors
12/26/2007EP1869017A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
12/26/2007EP1869010A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
12/26/2007EP1869009A1 New bicyclic angiotensin ii agonists
12/26/2007EP1869008A1 Inhibitors of prolyl endopeptidase
12/26/2007EP1869006A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists
12/26/2007EP1869002A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
12/26/2007EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
12/26/2007EP1868994A1 Sulfonylpyrroles as histone deacetylase inhibitors